1.Haas, M, Hall, J, Viney, R, Gallego, G. Breaking up is hard to do: Why disinvestment in medical technology is harder than investment. Aust Health Rev. 2012;36:148–152.
2.Henshall, C, Schuller, T, Mardhani-Bayne, L. Using health technology assessment to support optimal use of technologies in current practice: The challenge of “disinvestment”. Int J Technol Assess Health Care. 2012;28:203.
7.Bryan, S, Mitton, C, Donaldson, C. Breaking the addiction to technology adoption. Health Econ. 2014;23:379–383.
8.Elshaug, AG, Moss, JR, Littlejohns, P, Karnon, J, Merlin, TL, Hiller, JE. Identifying existing health care services that do not provide value for money. Med J Aust. 2009;190:269–273.
9.Noseworthy, T, Clement, F. Health technology reassessment: Scope, methodology, & language. Int J Technol Assess Health Care. 2012;28:201.
10.Soril, LJ, MacKean, G, Noseworthy, TW, Leggett, LE, Clement, FM. Achieving optimal technology use: A proposed model for health technology reassessment. SAGE Open Med. 2017;5: 2050312117704861.
11.Chambers, JD, Salem, MN, D'Cruz, BN, Subedi, P, Kamal-Bahl, SJ, Neumann, PJ. A review of empirical analyses of disinvestment initiatives. Value Health. 2017;20:909–918.
12.Leggett, L, Noseworthy, TW, Zarrabi, M, Lorenzetti, D, Sutherland, LR, Clement, FM. Health technology reassessment of non-drug technologies: Current practices. Int J Technol Assess Health Care. 2012; 28:220–227.
13.Leggett, LE, Mackean, G, Noseworthy, TW, Sutherland, L, Clement, F. Current status of health technology reassessment of non-drug technologies: Survey and key informant interviews. Health Res Policy Syst. 2012;10:38.
14.MacKean, G, Noseworthy, T, Elshaug, AG, et al. Health technology reassessment: The art of the possible. Int J Technol Assess Health Care. 2013;29:418–423.
15.Niven, DJ, Mrklas, KJ, Holodinsky, JK, et al. Towards understanding the de-adoption of low-value clinical practices: A scoping review. BMC Med. 2015;13:255.
16.Gnjidic, D, Elshaug, AG. De-adoption and its 43 related terms: Harmonizing low-value care terminology. BMC Med. 2015;13: 273.
17.Mayer, J, Nachtnebel, A. Disinvesting from ineffective technologies: Lessons learned from current programs. Int J Technol Assess Health Care. 2015;31:355–362.
18.Seo, H-J, Park, JJ, Lee, SH. A systematic review on current status of health technology reassessment: Insights for South Korea. Health Res Policy Syst. 2016;14:82.
19.Porter, ME. What is value in health care? N Engl J Med. 2010;363:2477–2481.
20.Elshaug, AG, Rosenthal, MB, Lavis, JN, et al. Levers for addressing medical underuse and overuse: Achieving high-value health care. Lancet. 2017;390:191–202.
21.Bhatia, RS, Levinson, W, Shortt, S, et al. Measuring the effect of Choosing Wisely: An integrated framework to assess campaign impact on low-value care. BMJ Qual Saf. 2015;24:523–531.
22.Morgan, DJ, Brownlee, S, Leppin, AL, et al. Setting a research agenda for medical overuse. BMJ. 2015;351:h4534.
23.Elshaug, AG, Hiller, JE, Tunis, SR, Moss, JR. Challenges in Australian policy processes for disinvestment from existing, ineffective health care practices. Aust N Z Health Policy. 2007;4:23.
24.Scotland, G, Bryan, S. Why do health economists promote technology adoption rather than the search for efficiency? A proposal for a change in our approach to economic evaluation in health care. Med Decis Making. 2017;37:139–147.
25.Saini, V, Brownlee, S, Elshaug, AG, Glasziou, P, Heath, I. Addressing overuse and underuse around the world. Lancet. 2017;390: 105–107.
27.Elshaug, AG, Watt, AM, Mundy, L, Willis, CD. Over 150 potentially low-value health care practices: An Australian study. Med J Aust. 2012;197:556–560.
28.Paprica, PA, Culyer, AJ, Elshaug, AG, Peffer, J, Sandoval, GA. From talk to action: Policy stakeholders, appropriateness, and selective disinvestment. Int J Technol Assess Health Care. 2015;31:236–240.
29.Daniels, T, Williams, I, Robinson, S, Spence, K. Tackling disinvestment in health care services: The views of resource allocators in the English NHS. J Health Organ Manag. 2013;27:762–780.
30.Rooshenas, L, Owen-Smith, A, Hollingworth, W, Badrinath, P, Beynon, C, Donovan, JL. “I won't call it rationing. . .”: An ethnographic study of healthcare disinvestment in theory and practice. Soc Sci Med. 2015;128:273–281.
31.Grimshaw, JM, Thomas, RE, MacLennan, G, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess. 2004;8: iii-iv, 1–72.
32.Michie, S, Johnston, M, Francis, J, Hardeman, W, Eccles, M. From theory to intervention: Mapping theoretically derived behavioural determinants to behaviour change techniques. Applied Psychol. 2008;57:660–680.
33.Polisena, J, Clifford, T, Elshaug, AG, Mitton, C, Russell, E, Skidmore, B. Case studies that illustrate disinvestment and resource allocation decision-making processes in health care: A systematic review. Int J Technol Assess Health Care. 2013;29:174–184.
34.Prasad, V, Ioannidis, J. Evidence-based de-implementation for contradicted, unproven, and aspiring healthcare practices. Implement Sci. 2014;9:5908–5909.
35.Sevick, K, Soril, LJJ, MacKean, G, Noseworthy, TW, Clement, FM. Unpacking early experiences with health technology reassessment in a complex healthcare system. Int J Healthc Manag. 2017: 1–7.